Germany

This strengthens Germany’s premium pet food market presence

The acquisition builds on Boehringer Ingelheim’s broader investment in therapeutic vaccines.

The infrastructure will also reduce emissions and enable future sourcing of green methanol.

This will reduce antibiotic use and improve animal health.

This acquisition will establish a new frozen logistics hub to enhance distribution across Europe.

LENZELTA® is administered in two doses during the dry-off period, a stage when cows are particularly vulnerable to infection.

Mars has indicated it is exploring opportunities aligned with its long-term strategy.

The data enables internationally consistent calculation of the environmental footprint and provides a reliable basis for sound analysis.

The agreement is effective from March 2026, with automatic renewal provisions.